{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:47:06Z","timestamp":1793213226167,"version":"4.5.0"},"reference-count":48,"publisher":"Society of Nuclear Medicine","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2025,9,23]]},"published-print":{"date-parts":[[2025,12]]},"DOI":"10.2967\/jnumed.125.271332","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T15:05:18Z","timestamp":1760022318000},"page":"1863-1870","source":"Crossref","is-referenced-by-count":9,"title":["SNMMI\/EANM\/ACNM Procedure Standard\/Procedure Guideline on the Use of Molecular Imaging for Renal Mass Characterization"],"prefix":"10.2967","volume":"66","author":[{"given":"Steven P.","family":"Rowe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian M.","family":"Shuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark W.","family":"Ball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Bex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrbod S.","family":"Javadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Klitzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolien","family":"Goffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Mulders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeta","family":"Pandit-Taskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwin Singh","family":"Parihar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin L.","family":"Viglianti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Gorin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"key":"2026030506250578000_66.12.1863.1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djj362"},{"key":"2026030506250578000_66.12.1863.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2012.12.049"},{"key":"2026030506250578000_66.12.1863.3","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/MNM.0000000000000618","article-title":"Diagnostic performance of 18F-FDG PET or PET\/CT in restaging renal cell carcinoma: a systematic review and meta-analysis","volume":"38","author":"Ma","year":"2017","journal-title":"Nucl Med Commun."},{"key":"2026030506250578000_66.12.1863.4","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1007\/s11604-025-01761-1","article-title":"Role of 18F-FDG-PET in renal tumors: insights from WHO 2022 classification","volume":"43","author":"Hirota","year":"2025","journal-title":"Jpn J Radiol."},{"key":"2026030506250578000_66.12.1863.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.07.072"},{"key":"2026030506250578000_66.12.1863.6","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/bju.13763","article-title":"Surgical histopathology for suspected oncocytoma on renal mass biopsy: a systematic review and meta-analysis","volume":"119","author":"Patel","year":"2017","journal-title":"BJU Int."},{"key":"2026030506250578000_66.12.1863.7","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.acra.2014.07.023","article-title":"CT texture analysis of renal masses: pilot study using random forest classification for prediction of pathology","volume":"21","author":"Raman","year":"2014","journal-title":"Acad Radiol."},{"key":"2026030506250578000_66.12.1863.8","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1148\/radiol.211680","article-title":"Multicenter evaluation of multiparametric MRI clear cell likelihood scores in solid indeterminate small renal masses","volume":"303","author":"Schieda","year":"2022","journal-title":"Radiology."},{"key":"2026030506250578000_66.12.1863.9","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21713"},{"key":"2026030506250578000_66.12.1863.10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.41.2445"},{"key":"2026030506250578000_66.12.1863.11","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13550-017-0329-5","article-title":"Correlation of 99mTc-sestamibi uptake in renal masses with mitochondrial content and multi-drug resistance pump expression","volume":"7","author":"Rowe","year":"2017","journal-title":"EJNMMI Res."},{"key":"2026030506250578000_66.12.1863.12","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S1470-2045(24)00402-9","article-title":"[89Zr]Zr-girentuximab for PET-CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trial","volume":"25","author":"Shuch","year":"2024","journal-title":"Lancet Oncol."},{"key":"2026030506250578000_66.12.1863.13","doi-asserted-by":"crossref","first-page":"20170526","DOI":"10.1259\/bjr.20170526","article-title":"99mTc-sestamibi SPECT\/CT for the characterization of renal masses: a pictorial guide","volume":"91","author":"Campbell","year":"2018","journal-title":"Br J Radiol."},{"key":"2026030506250578000_66.12.1863.14","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.urology.2017.11.015","article-title":"Use of 99mTc-sestamibi single-photon emission computed tomography\/x-ray computed tomography in the diagnosis of hybrid oncocytic\/chromophobe tumor in a pediatric patient","volume":"113","author":"Almassi","year":"2018","journal-title":"Urology."},{"key":"2026030506250578000_66.12.1863.15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/RLU.0000000000000670","article-title":"Initial experience using 99mTc-MIBI SPECT\/CT for the differentiation of oncocytoma from renal cell carcinoma","volume":"40","author":"Rowe","year":"2015","journal-title":"Clin Nucl Med."},{"key":"2026030506250578000_66.12.1863.16","first-page":"802","article-title":"Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy","volume":"9","author":"Bui","year":"2003","journal-title":"Clin Cancer Res."},{"key":"2026030506250578000_66.12.1863.17","doi-asserted-by":"crossref","first-page":"661","DOI":"10.21873\/cdp.10157","article-title":"CAIX Immunostaining in non-neoplastic renal diseases","volume":"2","author":"Yousef","year":"2022","journal-title":"Cancer Diagn Progn."},{"key":"2026030506250578000_66.12.1863.18","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1200\/JCO.1993.11.4.738","article-title":"Antibody localization in human renal cell carcinoma: a phase I study of monoclonal antibody G250","volume":"11","author":"Oosterwijk","year":"1993","journal-title":"J Clin Oncol."},{"key":"2026030506250578000_66.12.1863.19","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(07)70044-X"},{"key":"2026030506250578000_66.12.1863.20","doi-asserted-by":"crossref","first-page":"C178","DOI":"10.1152\/ajpcell.1993.265.1.C178","article-title":"Microprobe analysis of Tc-MIBI in heart cells: calculation of mitochondrial membrane potential","volume":"265","author":"Backus","year":"1993","journal-title":"Am J Physiol."},{"key":"2026030506250578000_66.12.1863.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.02.024"},{"key":"2026030506250578000_66.12.1863.22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0090-4295(96)00095-7","article-title":"Renal oncocytoma: preoperative diagnosis using technetium 99m sestamibi imaging","volume":"48","author":"Gormley","year":"1996","journal-title":"Urology."},{"key":"2026030506250578000_66.12.1863.23","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.eururo.2015.08.056","article-title":"Prospective Evaluation of 99mTc-sestamibi SPECT\/CT for the diagnosis of renal oncocytomas and hybrid oncocytic\/chromophobe tumors","volume":"69","author":"Gorin","year":"2016","journal-title":"Eur Urol."},{"key":"2026030506250578000_66.12.1863.24","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/JU.0000000000003557","article-title":"Clinical performance of technetium-99m-sestamibi SPECT\/CT imaging in differentiating oncocytic tumors from renal cell carcinoma in routine clinical practice","volume":"210","author":"Schober","year":"2023","journal-title":"J Urol."},{"key":"2026030506250578000_66.12.1863.25","doi-asserted-by":"crossref","first-page":"937.e11","DOI":"10.1016\/j.urolonc.2020.07.018","article-title":"The role of Tc-99m MIBI scintigraphy in clinical T1 renal mass assessment: does it have a real benefit?","volume":"38","author":"Asi","year":"2020","journal-title":"Urol Oncol."},{"key":"2026030506250578000_66.12.1863.26","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.264329"},{"key":"2026030506250578000_66.12.1863.27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13550-017-0278-z","article-title":"Visual evaluation and differentiation of renal oncocytomas from renal cell carcinomas by means of 99mTc-sestamibi SPECT\/CT","volume":"7","author":"Tzortzakakis","year":"2017","journal-title":"EJNMMI Res."},{"key":"2026030506250578000_66.12.1863.28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.eururo.2023.07.013","article-title":"The role of 99mTc-sestamibi single-photon emission computed tomography\/computed tomography in the diagnostic pathway for renal masses: a systematic review and meta-analysis","volume":"85","author":"Basile","year":"2024","journal-title":"Eur Urol."},{"key":"2026030506250578000_66.12.1863.29","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.euf.2020.02.010","article-title":"Cost-effectiveness analysis of 99mTc-sestamibi SPECT\/CT to guide management of small renal masses","volume":"7","author":"Su","year":"2021","journal-title":"Eur Urol Focus."},{"key":"2026030506250578000_66.12.1863.30","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.266309"},{"key":"2026030506250578000_66.12.1863.31","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.267175"},{"key":"2026030506250578000_66.12.1863.32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23116125"},{"key":"2026030506250578000_66.12.1863.33","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1007\/s00259-023-06248-7","article-title":"Preclinical and pilot clinical evaluation of a small-molecule carbonic anhydrase IX targeting PET tracer in clear cell renal cell carcinoma","volume":"50","author":"Zhu","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026030506250578000_66.12.1863.34","doi-asserted-by":"crossref","first-page":"33733","DOI":"10.18632\/oncotarget.5254","article-title":"Imaging of carbonic anhydrase IX with an 111In-labeled dual-motif inhibitor","volume":"6","author":"Yang","year":"2015","journal-title":"Oncotarget."},{"key":"2026030506250578000_66.12.1863.35","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/bju.16507","article-title":"The use of 99mTc-tetrofosmin in the characterisation of indeterminate renal masses: a pilot study","volume":"134","author":"Spiro","year":"2024","journal-title":"BJU Int."},{"key":"2026030506250578000_66.12.1863.36","doi-asserted-by":"crossref","first-page":"e0129627","DOI":"10.1371\/journal.pone.0129627","article-title":"Brown adipose tissue response dynamics: in vivo insights with the voltage sensor 18F-fluorobenzyl triphenyl phosphonium","volume":"10","author":"Madar","year":"2015","journal-title":"PLoS One."},{"key":"2026030506250578000_66.12.1863.37","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.juro.2017.08.079","article-title":"Comprehensive evaluation of prostate specific membrane antigen expression in the vasculature of renal tumors: implications for imaging studies and prognostic role","volume":"199","author":"Spatz","year":"2018","journal-title":"J Urol."},{"key":"2026030506250578000_66.12.1863.38","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.267417"},{"key":"2026030506250578000_66.12.1863.39","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.3390\/cancers12113393","article-title":"Altered tissue and plasma levels of fibroblast activation protein-a (FAP) in renal tumours","volume":"12","author":"Solano-Iturri","year":"2020","journal-title":"Cancers (Basel)."},{"key":"2026030506250578000_66.12.1863.40","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1007\/s00259-023-06461-4","article-title":"The role of [68Ga]Ga-FAPI-04 PET\/CT in renal cell carcinoma: a preliminary study","volume":"51","author":"Civan","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026030506250578000_66.12.1863.41","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.262647"},{"key":"2026030506250578000_66.12.1863.42","doi-asserted-by":"crossref","first-page":"e630","DOI":"10.1097\/RLU.0000000000005487","article-title":"Renal cell carcinoma with tumor thrombus extending into the inferior vena cava and the right atrium demonstrated by 68Ga-DOTATATE PET\/CT","volume":"49","author":"Filizoglu","year":"2024","journal-title":"Clin Nucl Med."},{"key":"2026030506250578000_66.12.1863.43","doi-asserted-by":"crossref","first-page":"e166","DOI":"10.1097\/RLU.0000000000001533","article-title":"Evaluation of a large renal mass using 99mTc-MIBI SPECT\/CT in a patient with chronic kidney disease","volume":"42","author":"Rowe","year":"2017","journal-title":"Clin Nucl Med."},{"key":"2026030506250578000_66.12.1863.44","doi-asserted-by":"crossref","first-page":"e188","DOI":"10.1097\/RLU.0000000000001534","article-title":"Defining the added value of 99mTc-MIBI SPECT\/CT to conventional cross-sectional imaging in the characterization of enhancing solid renal masses","volume":"42","author":"Sheikhbahaei","year":"2017","journal-title":"Clin Nucl Med."},{"key":"2026030506250578000_66.12.1863.45","unstructured":"CY 2025 Medicare Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System final rule (CMS 1809-FC). Centers for Medicare and Medicaid Services website. https:\/\/www.cms.gov\/newsroom\/fact-sheets\/cy-2025-medicare-hospital-outpatient-prospective-payment-system-and-ambulatory-surgical-center-0. Accessed September 25, 2025."},{"key":"2026030506250578000_66.12.1863.46","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.clinimag.2022.11.007","article-title":"CT radiomics for differentiating oncocytoma from renal cell carcinomas: systematic review and meta-analysis","volume":"94","author":"Dehghani Firouzabadi","year":"2023","journal-title":"Clin Imaging."},{"key":"2026030506250578000_66.12.1863.47","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/pros.24483","article-title":"Lack of repeatability of radiomic features derived from PET scans: results from a 18F-DCFPyL test-retest cohort","volume":"83","author":"Werner","year":"2023","journal-title":"Prostate."},{"key":"2026030506250578000_66.12.1863.48","doi-asserted-by":"crossref","unstructured":"Klontzas ME Koltsakis E Kalarakis G . Machine learning integrating 99mTc sestamibi SPECT\/CT and radiomics data achieves optimal characterization of renal oncocytic tumors. Cancers (Basel). 2023;15.","DOI":"10.3390\/cancers15143553"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.125.271332","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T20:18:40Z","timestamp":1785269920000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.125.271332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":48,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12,3]]},"published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.2967\/jnumed.125.271332"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.125.271332","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]}}}